Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an AI app help MS patients get stronger at home?

NCT ID NCT06871072

Symptom relief Sponsor: University of Cadiz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study tested whether an artificial intelligence (AI) app could help people with multiple sclerosis (MS) improve their strength through home-based exercise. Fifty-eight adults with MS followed a 20-week strength training program, with one group using the AI app for guidance and feedback, and the other using paper instructions and videos. The goal was to see if the AI approach could boost strength, mobility, and quality of life more than the conventional method.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-powered telerehabilitation app (RehBody) for strength training
What this could lead to
If successful, this could offer a convenient, AI-guided way for people with MS to improve strength and quality of life from home.
What could go wrong
This is a small, completed trial (58 participants) with no phase designation, so results may not apply broadly. The AI app's benefits over conventional methods are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

58 people

The number who actually took part.

Started

Apr 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of multiple sclerosis according to the McDonald criteria 2017: * Age between 35 and 60 years. * Score on the Expanded Disability Status Scale in Multiple Sclerosis by Kurtzke (EDSS) between 2 and 6 points. * Patients who do not require assistive devices for home mobility. * Patients with no changes in disease-modifying treatment in the last 3 months. * Patients who have understood, completed, and signed the informed consent and the study information sheet. Exclusion Criteria: * Patients who have been regularly performing strength exercises for more than 3 months prior. * Moderate/severe cognitive impairment that may interfere with the understanding and/or execution of the study. * History of alcohol and/or drug abuse. * Presence of a relapse and/or treatment with corticosteroids within the four weeks prior to the start of the study. * Patients with severe comorbidities other than MS that may pose a risk for following the exercise guidelines or for their participation in the study for other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

Contacts and locations

Locations

  • Macarena University Hospital

    Seville, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.